Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for iBio (IBIO) over the last 15 years, with Q4 2025 value amounting to $30.1 million.

  • iBio's Shares Outstanding rose 22779.23% to $30.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $30.1 million, marking a year-over-year increase of 22779.23%. This contributed to the annual value of $19.3 million for FY2025, which is 12436.22% up from last year.
  • As of Q4 2025, iBio's Shares Outstanding stood at $30.1 million, which was up 22779.23% from $20.3 million recorded in Q3 2025.
  • Over the past 5 years, iBio's Shares Outstanding peaked at $216.1 million during Q1 2021, and registered a low of $437000.0 during Q2 2022.
  • Moreover, its 5-year median value for Shares Outstanding was $8.7 million (2021), whereas its average is $18.7 million.
  • As far as peak fluctuations go, iBio's Shares Outstanding tumbled by 9596.27% in 2022, and later surged by 97673.83% in 2024.
  • Quarter analysis of 5 years shows iBio's Shares Outstanding stood at $8.7 million in 2021, then plummeted by 92.9% to $619000.0 in 2022, then skyrocketed by 424.07% to $3.2 million in 2023, then surged by 182.61% to $9.2 million in 2024, then skyrocketed by 227.79% to $30.1 million in 2025.
  • Its last three reported values are $30.1 million in Q4 2025, $20.3 million for Q3 2025, and $19.3 million during Q2 2025.